Navigation Links
Bionovo Announces Third Quarter 2010 Highlights and Financial Results
Date:11/11/2010

ating expenses:Research and development

3,6732,93810,8079,49350,513General and administrative

9879262,6273,11020,229Merger cost

----1,964Total operating expenses

4,6603,86413,43412,60372,706Loss from operations

(4,592)(3,709)(13,352)(12,441)(71,444)Change in fair value of warrant liability

----831Interest income

2516752,090Interest expense

(9)(22)(33)(77)(493)Other expense

(28)-(39)(86)(206)Net loss

$
(4,627)$
(3,726)$  (13,408)$  (12,529)$
(69,222)Basic and diluted net loss per common share

$
(0.21)$
(0.24)$
(0.62)$
(0.82)$
(6.58)Shares used in computing basic and diluted
net loss per share

21,78515,28721,60715,27810,517Bionovo, Inc.(A Development Stage Company)Consolidated Balance Sheets(in thousands, except share amounts)September 30,
2010December 31,
2009(unaudited)ASSETSCurrent assets:Cash and cash equivalents

$
3,113$
2,799Short-term investments

-13,135Receivables

69251Prepaid expenses

1,133214Other current assets

232161Total current assets

4,54716,560Property and equipment, net

7,1216,197Patent pending, net

1,187822Other assets

1,184570Total assets

$
4,039$
24,149LIABILITIES AND SHAREHOLDERS’ EQUITYCurrent liabilities:Accounts payable

$
386$
311Accrued compensation and benefits

344367Current portion of capital lease obligations

1,123476Current portion of notes payable

5459Other current liabilities

1,194823Total current liabilities

3,1012,036Non-current portion of capital lease obligations

1,01996Non-current portion of notes payable

83121Total liabilities

4,2032,253Commitments and contingenciesShareholders’ equity:Preferred stock, $0.0001 par value; 2,000,000 shares authorized; none issued and outstanding

--Common stock $0.0001 par value, 68,000,000 sha
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Bionovo, Inc. to Announce Third Quarter Fiscal Year 2010 Financial Results on Thursday, November 11, 2010
2. Bionovo Announces Publication Describing Potential Estrogen Receptor Modulating Drugs for Treating Menopausal Conditions
3. Bionovo to Raise $3 Million Through Registered Direct Offering
4. Bionovo to Present at the JMP Securities Healthcare Conference
5. Bionovo to Present at Cambria Capital Investor Meeting
6. Bionovo Receives Positive Guidance from FDA on Menerba®
7. Bionovo Announces Reverse Stock Split
8. Bionovo Announces Publication Describing Menerbas Effect on Neural Pathways Related to Temperature Regulation
9. Bionovo to Advance Menerba to Phase 3 Clinical Testing in Europe
10. Bionovo, Inc. to Announce Second Quarter Fiscal Year 2010 Financial Results on Wednesday, August 4, 2010
11. Bionovo Announces a $15 Million At-The-Market Firm Commitment Financing Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... , Sept. 18, 2014 Australian biomarker discovery ... US trial of its MiStat™ prostate cancer screening test, ... regulatory approval upon completion. Minomic,s proprietary MiStat™ ... presence of a proprietary biomarker known as the MIL-38 ... prostate cancer cells. Researchers at 11 ...
(Date:9/18/2014)...  Spring Bank Pharmaceuticals, Inc., a clinical-stage biopharmaceutical ... RNA viruses, today announced a research collaboration with ... testing of the Company,s lead compound, SB 9200, ... against which currently there are no effective antiviral ... proprietary Small Molecule Nucleic Acid Hybrid (SMNH) ...
(Date:9/18/2014)... /CNW/ - A new expert panel report, Improving Medicines ... released today by the Council of Canadian Academies, addresses ... children. Each year about half of Canada,s ... prescription drug. Much of this prescribing is done off-label ... potential health risks. Children have historically been ...
Breaking Medicine Technology:Minomic Launches US Pilot Study of MiStat(TM) Novel Prostate Cancer Screening Technology 2Spring Bank Pharmaceuticals Announces NIH Collaboration for Testing of SB 9200 Against Multiple Viral Pathogens 2Studying medicines in children is always possible and is in their best interest, finds Expert Panel 2Studying medicines in children is always possible and is in their best interest, finds Expert Panel 3
... major personalized medicine advances will create therapies that are so ... industry to gain access, the inventor of the DNA gene ... Personalized Health Care National Conference . ... Biology, said personalized medicine,s first "killer apps" - therapies that ...
... focus on complex cases, facility called ,future of hospital care, ... Dallas announces the opening of the Hamon Tower, the largest ... to intensive care for the region,s most critically ill patients. ... and new clinical programs for ICU patients, Hamon Tower is ...
Cached Medicine Technology:Personalized Medicine 'Killer Apps' Will Transform Care Model 2Hamon Tower Features Critical Care Advances, Potential for Reduced Costs 2
(Date:9/18/2014)... HealthDay Reporter , THURSDAY, Sept. 18, 2014 ... antidepressant can quickly alter the way brain cells communicate with ... Sept. 18 in Current Biology , are a ... antidepressants. Experts said the hope is to eventually be able ... from a drug -- and which people would fare better ...
(Date:9/18/2014)... 19, 2014 In 2003, ... Mission (Misión Barrio Adentro), which it hoped ... system (see Section 6.1.3.). In 2009, it ... Autonomous Service of Pharmaceutical Elaborations (Servicio Autónomo ... provides medicines at a cheaper rate than ...
(Date:9/18/2014)... 18, 2014 Ben Quirk, CEO of ... Jr. Leadership Award by the Savannah Science Seminar in ... wellness throughout the nation and especially in Savannah. , ... said Ben. “The Savannah Science Seminar is an amazing ... multiple generations have gone through the program,” he added. ...
(Date:9/18/2014)... convene a one-day conference at the Milken Institute School ... September 25, 2014 to discuss the Global Health Security ... purpose of this event is to invite discussion of ... years, including action plans to curtail the current deadly ... GHSA, international organizations and more than 50 countries have ...
(Date:9/18/2014)... N.C. Dangerous new pathogens such as the Ebola ... ancient scourges such as the bubonic plague are still ... responds to infections. , In a study published online ... researchers at Duke Medicine and Duke-NUS Graduate Medical School ... bubonic plague hitchhike on immune cells in the lymph ...
Breaking Medicine News(10 mins):Health News:One Dose of Antidepressant Changes Brain Connections, Study Says 2Health News:One Dose of Antidepressant Changes Brain Connections, Study Says 3Health News:Venezuela Pharmaceutical Market worth $22.2 billion with 12% CAGR by 2020 Says a New Report Available at MarketOptimizer.org 2Health News:Venezuela Pharmaceutical Market worth $22.2 billion with 12% CAGR by 2020 Says a New Report Available at MarketOptimizer.org 3Health News:Venezuela Pharmaceutical Market worth $22.2 billion with 12% CAGR by 2020 Says a New Report Available at MarketOptimizer.org 4Health News:Quirk Awarded the Alex Ormond, Jr. Leadership Award by the Savannah Science Seminar 2Health News:Non-governmental stakeholders to discuss the Global Health Security Agenda 2Health News:New insights on an ancient plague could improve treatments for infections 2
... Orissa government has ordered administrations of all 30 districts to ... three days.// ,The officials were Thursday asked to ... senior health department official. ,These would then be ... government does not have testing facilities to confirm the presence ...
... safety lawyer, writes about why it is essential for us ... that there is a major defect in the food safety ... people affected or even killed by contaminated food products from ... it prevents our society from knowing the source of our ...
... of NSAID by women in their first trimester could ... ,Non-steroidal anti-inflammatory drugs, NSAIDs, Cardiac septal defects, Journal ... Congenital abnormality, Diabetes ,Women who take non-steroidal ... more likely to give birth to babies with congenital ...
... say that a commonly used HIV drug may be useful ... be used in prevention of the cancer and could be ... and his colleagues said that such a cream could prove ... lesions. However no clinical trials have begun as yet. ...
... hundreds of resident doctors in Delhi who had gone on ... agitation //for the next three months with the reservation bill ... the parliament has referred the reservation bill to the standing ... being. The bill will be placed in the floor of ...
... the University of Pennsylvania have disclosed that a specific ... of changing into bone, muscle, neurons or other// types ... environment. , ,The researchers found that ... bone marrow, are soliciting tangible clues from their local ...
Cached Medicine News:Health News:Importance of knowing the source of our food 2Health News:NSAIDs In First trimester Linked To Congenital Anomalies In Babies 2Health News:Medicos Suspends Anti-quota Stir 2Health News:Adult stem cells are sensitive to responses from the environment 2
Curved shafts with 4 mm tying platform. Serrated handle with dull finish. Manufactured in titanium. Overall length 3.3 inches....
Straight, 7 mm tying platform. Castroviejo handle. Manufactured in titanium. Overall length 4.2 inches....
Angled Castroviejo handle. Manufactured in titanium. Overall length 4.2 inches....
Straight shafts with 6 mm tying platform. Wide serrated handle with polished finish. Overall length 4.3 inches. Overall length 4.3 inches....
Medicine Products: